Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Prompt PRP for Proliferative Diabetic Retinopathy (Protocol S)
NCT01489189Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Mar 2012
- Primary completion
- Jan 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in proliferative diabetic retinopathy (PDR), sponsored by Jaeb Center for Health Research. Started Mar 2012; status: completed.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT01489189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489189.